WebAstraZeneca (US Rights for Toprol-XL) General Information Description. Portfolio of distribution rights for a beta-blocker medicine. The portfolio consists of U.S. distribution rights for the branded and authorized generic drug designed for the treatment of hypertension (high blood pressure), angina (chest pain) and heart failure. WebToprol XL Vabomere Minocin IV Senior Director, Value, Market Access, GPO and National Accounts Melinta Therapeutics Jan 2024 - Aug 2024 4 years 8 months. US - Field Based Lead a ...
Generic Metoprolol Reveals Flaws With FDA’s Approval Process
WebNew American Therapeutics. 300 Interpace Parkway Morris Corporate Center 1, Building C3 Parsippany, NJ 07054 United States. [email protected]. Send us a Message * * * * * . E-mail Us Site Map Terms ... WebMELINTA THERAPEUTICS INC : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen der Aktie MELINTA THERAPEUTICS INC US58549G1004 Nasdaq git dartmouth
AstraZeneca enters agreement with Aralez for beta-blocker …
Web6 apr. 2024 · MORRISTOWN, N.J., April 06, 2024--Melinta Therapeutics, LLC ("Melinta"), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today that it has acquired the U.S. rights to TOPROL-XL® (metoprolol succinate) and its Authorized Generic (AG) through an agreement between Melinta and … Web22 mrt. 2024 · About Melinta Therapeutics Melinta Therapeutics, LLC provides innovative therapies to people impacted by acute and life-threatening illnesses. Our portfolio currently includes six commercial-stage products: Baxdela ® (delafloxacin), Kimyrsa ® (oritavancin), Minocin ® (minocycline) for Injection, Orbactiv ® (oritavancin), TOPROL-XL ® … WebMELINTA THERAPEUTICS, INC. : Nieuws en informatie aandeel MELINTA THERAPEUTICS, INC. Deutsche Boerse AG gitc vs itgc